Covered recipient · General Payments record
MAUREEN A BLAIS-GESTRICH
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2022–2023
$791.49
- Reported across 30 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $334.94 | 17 |
| Education | $79.99 | 1 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $97.66 | 2 |
| Novo Nordisk AS | $80.67 | 4 |
| GlaxoSmithKline, LLC. | $56.79 | 3 |
| Lilly USA, LLC | $55.64 | 3 |
| ABBVIE INC. | $42.43 | 2 |
| IDORSIA PHARMACEUTICALS US INC | $42.13 | 2 |
| PFIZER INC. | $39.61 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.61 | 02/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003067015 | CMS |
| ABBVIE INC. | $20.82 | 08/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003067027 | CMS |
| Astellas Pharma US Inc | $17.67 | 08/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034435499 | CMS |
| Astellas Pharma US Inc | $79.99 | 09/07/2023 | Education | Undisputed | 01/23/2026 | 1034485029 | CMS |
| GlaxoSmithKline, LLC. | $16.59 | 06/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003592509 | CMS |
| GlaxoSmithKline, LLC. | $21.21 | 08/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003592501 | CMS |
| GlaxoSmithKline, LLC. | $18.99 | 09/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003592515 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $20.30 | 07/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034376729 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $21.83 | 09/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034376737 | CMS |
| Lilly USA, LLC | $18.57 | 03/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033247187 | CMS |
| Lilly USA, LLC | $14.28 | 06/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033445151 | CMS |
| Lilly USA, LLC | $22.79 | 08/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033249753 | CMS |
| Novo Nordisk Inc | $18.73 | 09/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001707639 | CMS |
| Novo Nordisk Inc | $23.99 | 09/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001707659 | CMS |
| Novo Nordisk Inc | $22.87 | 10/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001707649 | CMS |
| Novo Nordisk Inc | $15.08 | 11/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001707627 | CMS |
| PFIZER INC. | $20.26 | 02/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050539329 | CMS |
| PFIZER INC. | $19.35 | 06/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050659135 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.